CBD Life Sciences (CBD Life Sciences) Debt-to-Asset : 0.00 (As of Sep. 2015)

View and export this data going back to 2009. Start your Free Trial

What is CBD Life Sciences Debt-to-Asset?

CBD Life Sciences's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2015 was $0.00 Mil. CBD Life Sciences's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2015 was $0.00 Mil. CBD Life Sciences's Long-Term Debt & Capital Lease ObligationTotal Assets for the quarter that ended in Sep. 2015 was $0.62 Mil. CBD Life Sciences's debt to asset for the quarter that ended in Sep. 2015 was 0.00.

CBD Life Sciences Debt-to-Asset Historical Data

The historical data trend for CBD Life Sciences's Debt-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CBD Life Sciences Debt-to-Asset Chart

CBD Life Sciences Annual Data

Trend

Dec11

Dec12

Dec13

Dec14

Debt-to-Asset

CBD Life Sciences Quarterly Data
	Dec11	Mar12	Jun12	Sep12	Dec12	Mar13	Jun13	Sep13	Dec13	Mar14	Jun14	Sep14	Dec14	Mar15	Jun15	Sep15
Debt-to-Asset	Get a 7-Day Free Trial											-	-	-	-	-

Competitive Comparison of CBD Life Sciences's Debt-to-Asset

For the Drug Manufacturers - Specialty & Generic subindustry, CBD Life Sciences's Debt-to-Asset, along with its competitors' market caps and Debt-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

CBD Life Sciences's Debt-to-Asset Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, CBD Life Sciences's Debt-to-Asset distribution charts can be found below:

* The bar in red indicates where CBD Life Sciences's Debt-to-Asset falls into.

CBD Life Sciences Debt-to-Asset Calculation

Debt to Asset measures the financial leverage a company has.

CBD Life Sciences's Debt-to-Asset for the fiscal year that ended in Dec. 2014 is calculated as

Debt-to-Asset	=	Total Debt			/	Total Assets
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Assets
	=	(0	+	0)	/	0.632
	=	0.00

CBD Life Sciences's Debt-to-Asset for the quarter that ended in Sep. 2015 is calculated as

Debt-to-Asset	=	Total Debt			/	Total Assets
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Assets
	=	(0	+	0)	/	0.621
	=	0.00

CBD Life Sciences (OTCPK:CBDL) Debt-to-Asset Explanation

In the calculation of Debt-to-Asset, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Assets.

CBD Life Sciences Debt-to-Asset Related Terms

Thank you for viewing the detailed overview of CBD Life Sciences's Debt-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.

CBD Life Sciences (CBD Life Sciences) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » CBD Life Sciences Inc (OTCPK:CBDL) » Definitions » Debt-to-Asset

Comparable Companies

Traded in Other Exchanges

N/A

Address

10853 N. Frank Llyod Wright Boulevard, Suite 108, Scottsdale, AZ, USA, 85259

Website

https://lbcbioscienceinc.com

CBD Life Sciences Inc is developing and marketing a line of cannabidiol based organic products such as hemp drops, massage oils, recovery pain relief creams, anxiety and sleep solutions supplements, edibles, and a full line of pet products. The company is also in the process of developing an anti-aging skin product line.